phenacyl bromide has been researched along with su 11248 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdulwahab, HG; Al-Hussain, SA; Al-Qurashi, NT; Farghaly, TA; Muhammad, ZA; Zaki, MEA | 1 |
1 other study(ies) available for phenacyl bromide and su 11248
| Article | Year |
|---|---|
Discovery of novel indolyl-1,2,4-triazole hybrids as potent vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitors with potential anti-renal cancer activity.
Topics: Acetophenones; Antineoplastic Agents; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Indoles; Kidney Neoplasms; Molecular Docking Simulation; Molecular Structure; Protein Kinase Inhibitors; Structure-Activity Relationship; Sunitinib; Triazoles; Vascular Endothelial Growth Factor Receptor-2 | 2020 |